AngioDynamics (ANGO) vs Sanara MedTech (SMTI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
AngioDynamics (ANGO) has outperformed Sanara MedTech (SMTI) over the past year, gaining 28.4% versus a gain of 15.6%. Over five years, SMTI leads with a +6.3% price change compared with -48.2% for ANGO. AngioDynamics is the larger company by market cap ($596.8 million vs $322.0 million), about 1.9 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ANGO | SMTI |
|---|---|---|
| Share price | $14.19 | $35.05 |
| Market cap | $596.75M | $322.04M |
| 1-day change | -1.60% | +0.14% |
| YTD return | +10.51% | +50.11% |
| 1-year return | +28.42% | +15.56% |
| 5-year return | -48.15% | +6.28% |
| Forward P/E | — | 64.91 |
| EPS (TTM) | $-0.88 | $-0.04 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $16.29 | $35.34 |
| 52-week low | $9.39 | $16.05 |
| Distance from 52-week high | -12.89% | -0.82% |
| Analyst consensus | none | none |
| Avg. price target upside | +40.94% | -0.14% |
| Average volume | 506.32K | 276.85K |
| Shares outstanding | 42.05M | 9.19M |
| Employees | 632 | 108 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Instruments & Supplies | Medical Instruments & Supplies |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ANGO has outperformed SMTI by 12.9 percentage points over the past year.
About AngioDynamics
ANGO stock →AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells products for the treatment of cardiovascular disease and cancer diagnoses in the United States and internationally. The company operates through Med Tech and Med Device segments.
Healthcare · Medical Instruments & Supplies · 632 employees
About Sanara MedTech
SMTI stock →Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical solutions to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns.
Healthcare · Medical Instruments & Supplies · 108 employees
ANGO vs SMTI FAQ
Which is bigger, AngioDynamics or Sanara MedTech?
AngioDynamics (ANGO) is larger, with a market capitalization of $596.75M compared with $322.04M for Sanara MedTech (SMTI).
Which stock has performed better over the past year, ANGO or SMTI?
ANGO returned +28.42% over the past 12 months, compared with +15.56% for SMTI (price return, excluding dividends). Past performance does not predict future results.
Are AngioDynamics and Sanara MedTech in the same industry?
Yes. Both are classified in the Medical Instruments & Supplies industry within the Healthcare sector.